{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:56:01Z","timestamp":1790070961068,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.nucmedbio.2010.06.011","type":"journal-article","created":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T08:55:41Z","timestamp":1283417741000},"page":"113-120","source":"Crossref","is-referenced-by-count":17,"title":["Neurotensin(8\u201313) analogue: radiolabeling and biological evaluation using different chelators"],"prefix":"10.1016","volume":"38","author":[{"given":"Rodrigo","family":"Teodoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bluma Linkowski","family":"Faintuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eutimio Gustavo Fern\u00e1ndez","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Guimar\u00e3es","family":"Queir\u00f3z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.nucmedbio.2010.06.011_bb0005","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.addr.2008.04.006","article-title":"Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides","volume":"60","author":"Shuang","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.nucmedbio.2005.09.002","article-title":"Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice","volume":"33","author":"Vanderheyden","year":"2006","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0015","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00006231-199207000-00005","article-title":"The stability of technetium-99m directly labeled to a Fab\u2032 antibody via stannous ion and mercaptoethanol reduction","volume":"13","author":"Mardirossian","year":"1992","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0020","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1007\/s002590000343","article-title":"Influence of different chelators (HYNIC, MAG3 AND DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled to antisense DNA","volume":"27","author":"Zhang","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0025","first-page":"2022","article-title":"Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats","volume":"31","author":"Abrams","year":"1990","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0030","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.nucmedbio.2008.05.009","article-title":"Radiolabeling of annexin A5 with 99mTc: comparison of HYNIC-TC vs iminothiolane-Tc-tricarbonyl conjugates","volume":"35","author":"Biechlin","year":"2008","journal-title":"Nucl Med and Biol"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0035","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/bc980105f","article-title":"Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins","volume":"10","author":"Ono","year":"1999","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1021\/bc950069+","article-title":"Labeling a hydrazino nicotinamide-modified cyclic IIb\/IIa receptor antagonist with 99mTc using aminocarboxylates as coligands","volume":"7","author":"Liu","year":"1996","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0045","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/bc9800116","article-title":"A novel ternary ligand system for 99mTc-labeling of hydrazino nicotinamide modified biologically active molecules using imine-N-containing heterocycles as coligands","volume":"9","author":"Liu","year":"1998","journal-title":"Bioconjug Chem"},{"issue":"7","key":"10.1016\/j.nucmedbio.2010.06.011_bb0050","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0883-2889(92)90152-5","article-title":"Preparation of the renal function imaging agent 99mTc-MAG3 starting from S-unprotected mercaptoacetyltriglycine","volume":"43","author":"Noll","year":"1992","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0003-2697(83)90426-8","article-title":"A new reagent which may be used to introduce sulfhydryl-groups into proteins, and its use in the preparation of conjugates for immunoassay","volume":"132","author":"Duncan","year":"1983","journal-title":"Anal Biochem"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0969-8051(97)00027-9","article-title":"Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA","volume":"24","author":"Winnard","year":"1997","journal-title":"Nucl Med Biol"},{"issue":"1","key":"10.1016\/j.nucmedbio.2010.06.011_bb0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ctrv.2007.07.017","article-title":"Peptides-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer","volume":"34","author":"Okarvi","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/bc025542f","article-title":"Synthesis of target-specific radiolabeled peptides for diagnostic imaging","volume":"14","author":"Fichna","year":"2003","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.nucmedbio.2006.10.004","article-title":"Chemical and biological characterization of new Re(CO)3\/[99mTc](CO)3 bombesin analogues","volume":"34","author":"Garcia-Garayoa","year":"2007","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0080","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1016\/S0021-9258(19)43429-7","article-title":"The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami","volume":"248","author":"Carraway","year":"1973","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0085","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1021\/jm060415g","article-title":"Toward stable N4-modified neurotensins for NTS1-receptor-targeted tumor imaging with 99mTc","volume":"49","author":"Nock","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1432-1033.1982.tb05913.x","article-title":"Synthesis and characterization of neurotensin analogues for structure\/activity relationship studies \u2014 acetyl-neurotensin-(8\u201313) is the shortest analogue with full binding and pharmacological activities","volume":"124","author":"Granier","year":"1982","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0095","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.nucmedbio.2006.01.007","article-title":"Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors","volume":"33","author":"Garcia-Garayoa","year":"2006","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0969-8051(02)00314-1","article-title":"In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors","volume":"29","author":"La Bella","year":"2002","journal-title":"Nucl Med Biol"},{"issue":"4","key":"10.1016\/j.nucmedbio.2010.06.011_bb0105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.nucmedbio.2008.02.005","article-title":"Radiolabeling bombesin analogs for prostate cancer diagnosis: preclinical studies","volume":"35","author":"Faintuch","year":"2008","journal-title":"Nucl Med Biol"},{"issue":"3","key":"10.1016\/j.nucmedbio.2010.06.011_bb0110","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/nprot.2006.262","article-title":"Methods for MAG3 conjugation and 99mTc radiolabeling of biomolecules","volume":"1","author":"Wang","year":"2006","journal-title":"Nature Protocols"},{"issue":"10","key":"10.1016\/j.nucmedbio.2010.06.011_bb0115","first-page":"1649","article-title":"Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients","volume":"44","author":"Buchegger","year":"2003","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.nucmedbio.2010.06.011_bb0120","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.peptides.2006.04.030","article-title":"Involvement of NT in cancer growth evidences, mechanisms and development of diagnostic tolls","volume":"27","author":"Carraway","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0125","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0006-291X(02)00703-9","article-title":"Neurotensin counteracts apoptosis in breast cancer cells","volume":"295","author":"Somai","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.nucmedbio.2010.06.011_bb0130","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.bmcl.2008.01.110","article-title":"Peptide backbone modifications on the C-terminal hexapeptide of neurotensin","volume":"18","author":"Einsiedel","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0969-8051(00)00190-6","article-title":"In vitro and in vivo evaluation of new radiolabeled neurotensin(8\u201313) analogues with high affinity for NT1 receptors","volume":"28","author":"Garcia-Garayoa","year":"2001","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0140","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1016\/j.bmc.2006.05.024","article-title":"Synthesis and evaluation of novel multimeric neurotensin(8\u201313) analogs","volume":"14","author":"Hultsch","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0969-8051(01)00278-5","article-title":"Nitriles form mixed-coligand complexes with 99mTc-HYNIC-peptide","volume":"29","author":"Liu","year":"2002","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0150","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0969-8051(96)00131-X","article-title":"Technetium-99m antibodies labeled with MAG3 and HYNIC \u2014 an in vitro and animal in vivo properties","volume":"23","author":"Lei","year":"1996","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0155","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/00006231-199511000-00011","article-title":"Comparative evaluation of 99mTc-HYNIC-HAS and 99mTc-MAG3-HAS as possible blood poll agents","volume":"16","author":"Verbke","year":"1995","journal-title":"Nucl Med Comm"},{"issue":"2","key":"10.1016\/j.nucmedbio.2010.06.011_bb0160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0969-8051(00)00200-6","article-title":"Plasma protein binding of 99mTc-labeled hydrazino nicotinamide derivatized polypeptides and peptides","volume":"28","author":"Ono","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0165","first-page":"195","article-title":"The influence of chelator on the pharmacokinetics of 99mTc-labelled peptides","volume":"46","author":"Decristoforo","year":"2002","journal-title":"Q. J. Nucl. Med."},{"key":"10.1016\/j.nucmedbio.2010.06.011_bb0170","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.nucmedbio.2006.09.001","article-title":"[99mTc]HYNIC-RGD for imaging integrin avb3 expression","volume":"33","author":"Decristoforo","year":"2006","journal-title":"Nucl. Med. Biol."}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805110003240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805110003240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:55:42Z","timestamp":1636332942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805110003240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0969805110003240"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2010.06.011","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}